Chevy Chase Trust Holdings LLC Sells 3,119 Shares of Colgate-Palmolive Company (NYSE:CL)

Chevy Chase Trust Holdings LLC lowered its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 0.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 433,055 shares of the company's stock after selling 3,119 shares during the quarter. Chevy Chase Trust Holdings LLC owned 0.05% of Colgate-Palmolive worth $40,577,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Cornerstone Wealth Management LLC raised its stake in Colgate-Palmolive by 1.2% in the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock valued at $847,000 after buying an additional 110 shares during the period. Axxcess Wealth Management LLC raised its stake in Colgate-Palmolive by 0.3% in the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company's stock valued at $3,526,000 after buying an additional 117 shares during the period. Wescott Financial Advisory Group LLC raised its stake in Colgate-Palmolive by 3.5% in the fourth quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company's stock valued at $320,000 after buying an additional 119 shares during the period. Aberdeen Wealth Management LLC grew its position in shares of Colgate-Palmolive by 0.6% in the fourth quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock valued at $1,877,000 after purchasing an additional 125 shares during the last quarter. Finally, Town & Country Bank & Trust CO dba First Bankers Trust CO increased its stake in shares of Colgate-Palmolive by 4.0% during the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock worth $317,000 after purchasing an additional 130 shares during the period. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of CL stock traded up $1.01 on Friday, hitting $88.80. 6,946,159 shares of the company's stock were exchanged, compared to its average volume of 4,801,067. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. Colgate-Palmolive Company has a 12 month low of $85.32 and a 12 month high of $109.30. The stock has a market cap of $71.97 billion, a P/E ratio of 25.09, a price-to-earnings-growth ratio of 4.66 and a beta of 0.38. The company has a 50 day moving average of $90.86 and a 200 day moving average of $90.60.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. Colgate-Palmolive's revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.86 EPS. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.34%. Colgate-Palmolive's dividend payout ratio is presently 58.76%.

Colgate-Palmolive declared that its board has approved a stock repurchase plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's management believes its shares are undervalued.

Analyst Ratings Changes

Several research firms recently issued reports on CL. Piper Sandler reduced their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Monday, March 31st. UBS Group boosted their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. Citigroup boosted their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. Finally, Barclays reduced their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $101.69.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.